デスモプレシンの市場：形態、販売チャネル、エンドユーザー別-2025-2030年の世界予測

デスモプレシン市場は、2023年に12億5,000万米ドルと評価され、2024年には13億米ドルに達すると予測され、CAGR 6.68%で成長し、2030年には19億7,000万米ドルになると予測されています。

デスモプレシンは抗利尿ホルモンであるバソプレッシンの合成アナログで、主に糖尿病性尿崩症、おねしょ（夜尿症）、von Willebrand病や軽度の血友病Aのような出血性疾患など、様々な病状を管理するために使用されます。デスモプレシンの必要性を理解するには、水分保持と凝固プロセスにおけるその効果的な役割が重要であり、正確な体液バランスと凝固調節を必要とする医療現場で不可欠なものとなっています。デスモプレシンの適用範囲は、病院、クリニック、在宅ヘルスケアに及び、錠剤、注射剤、点鼻薬などの形態で投与されます。最終用途は主にヘルスケア施設内であり、厳格な医療指導の下での在宅使用の可能性もあります。市場の洞察によると、主な成長促進要因は、中枢性糖尿病性不定愁訴のような疾患の有病率の増加、出血性疾患に対する意識の高まり、ドラッグデリバリーシステムの進歩です。人口の高齢化と夜尿症の発生率の上昇が需要の拡大に寄与しています。しかし、低ナトリウム血症（低血中ナトリウム血症）などの副作用、医薬品承認における規制上のハードル、高額な治療費などの課題が、市場成長の可能性を制限しています。新たな点鼻薬や舌下錠のような非侵襲的な投与形態や、新たな治療領域への適用拡大など、送達メカニズムの技術革新が進行中であることが好機です。こうした機会を活用するための推奨事項としては、製剤の効率性と安全性を向上させるための研究開発への投資、市場拡大のための戦略的パートナーシップの活用、疾患に対する認識が高まっている新興市場へのマーケティング努力の集中などが挙げられます。潜在的な副作用や代替療法との競合といった課題は依然として困難であるが、製剤の改善や費用対効果の高いソリューションを通じてこれらに対処することで、競争力を高めることができます。技術革新の分野は、治療レジメンの最適化と、アンメット・メディカル・ニーズのある他の疾患の治療におけるアンメット・キーワードの使用に焦点を当てるべきです。市場の性質はダイナミックであり、規制の変更や進化するヘルスケア需要への継続的な適応が必要となります。

市場力学：急速に進化するデスモプレシン市場の主要市場インサイトを公開

デスモプレシン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の糖尿病患者の増加
  • 糖尿病の認識と治療を支援する政府の取り組みとプログラム
• 市場抑制要因
  • デスモプレシンに関連する副作用
• 市場機会
  • 新製剤の研究開発活動の継続
  • デスモプレシンに対する規制当局の承認の増加
• 市場の課題
  • 代替医薬品の入手可能性

ポーターのファイブフォース：デスモプレシン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：デスモプレシン市場における外部からの影響の把握

外部マクロ環境要因は、デスモプレシン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析デスモプレシン市場における競合情勢の把握

デスモプレシン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスデスモプレシン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、デスモプレシン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨デスモプレシン市場における成功への道筋を描く

デスモプレシン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で尿崩症患者の増加
    • 糖尿病の啓発と治療を支援する政府の取り組みとプログラム
  • 抑制要因
    • デスモプレシンに関連する悪影響
  • 機会
    • 新しい処方のための継続的な研究開発活動
    • デスモプレシンの規制承認の増加
  • 課題
    • 代替医療の入手可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 デスモプレシンの市場：形態別

• 注射液
• 鼻スプレー
• 錠剤

第7章 デスモプレシンの市場：販売チャネル別

• オフライン
• オンライン

第8章 デスモプレシンの市場：エンドユーザー別

• ホームケア
• 病院
• 専門クリニック

第9章 南北アメリカのデスモプレシンの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のデスモプレシンの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのデスモプレシンの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AA Pharma Inc.
• Amring Pharmaceuticals Inc.
• Antares Pharma, Inc. by Halozyme, Inc.
• Apotex Inc.
• Avadel Pharmaceuticals PLC
• Bachem AG
• BluePoint Laboratories
• CSC Pharmaceuticals International
• Dr. Reddy's Laboratories Ltd.
• Enomark
• Ferring Pharmaceuticals
• Glenmark Pharmaceuticals Limited
• Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
• KVR Pharmaceuticals
• Manus Aktteva Biopharma LLP
• Midas Pharma GmbH
• NorthStar Rx LLC
• Pfizer Inc.
• Ralington Pharma LLP
• Saintroy Lifescience
• Sanofi S.A.
• Sava Healthcare Limited
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• VIVAN Life Sciences Pvt. Limited

LIST OF FIGURES

• FIGURE 1. DESMOPRESSIN MARKET RESEARCH PROCESS
• FIGURE 2. DESMOPRESSIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DESMOPRESSIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DESMOPRESSIN MARKET DYNAMICS
• TABLE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 28. CANADA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 29. CANADA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. CHINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 46. CHINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 48. INDIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. INDIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 100. ITALY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. ITALY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 112. POLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. POLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 115. QATAR DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 116. QATAR DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 145. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023

The Desmopressin Market was valued at USD 1.25 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 6.68%, to USD 1.97 billion by 2030.

Desmopressin, a synthetic analog of the antidiuretic hormone vasopressin, is primarily used to manage various medical conditions such as diabetes insipidus, bedwetting (nocturnal enuresis), and bleeding disorders like von Willebrand's disease and mild hemophilia A. Understanding the necessity of desmopressin hinges on its effective role in water retention and coagulation processes, making it vital in medical settings that require precise fluid balance and clotting regulation. The application scope of desmopressin spans hospitals, clinics, and home healthcare settings where it is administered in forms such as tablets, injectables, and nasal sprays. The end-use is mainly within healthcare facilities, with potential home use under strict medical guidance. Market insights indicate that the primary growth drivers are increasing prevalence rates of conditions like central diabetes insipidus, heightened awareness about bleeding disorders, and advancements in drug delivery systems. Aging populations and the rising incidence of nocturnal enuresis contribute to expanding the demand. However, challenges such as side effects, including hyponatremia (low blood sodium), regulatory hurdles in drug approval, and high therapy costs limit market growth potential. Opportunities abound in the ongoing innovation of delivery mechanisms, particularly non-invasive delivery forms like novel nasal sprays or sublingual tablets, and extending applications to newer therapeutic areas. Recommendations for capitalizing on these opportunities include investing in R&D to improve formulation efficiency and safety, leveraging strategic partnerships for market expansion, and focusing marketing efforts on emerging markets where disease awareness is increasing. Limitations such as potential side effects and competition from alternative therapies remain challenging; however, addressing these through improved drug formulations and cost-effective solutions could provide a competitive edge. Areas of innovation should focus on optimizing therapeutic regimens and exploring the use of desmopressin in treating other conditions with unmet medical needs. The market's nature is dynamic, necessitating continuous adaptation to regulatory changes and evolving healthcare demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Desmopressin Market

The Desmopressin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising occurrence of diabetes insipidus in patients worldwide
  • Government initiatives and programs supporting diabetes awareness & treatment
• Market Restraints
  • Adverse effects associated with the desmopressin
• Market Opportunities
  • Ongoing research & development activities for new formulations
  • Increasing in regulatory approvals for desmopressin
• Market Challenges
  • Availability of alternative medicines

Porter's Five Forces: A Strategic Tool for Navigating the Desmopressin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Desmopressin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Desmopressin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Desmopressin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Desmopressin Market

A detailed market share analysis in the Desmopressin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Desmopressin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Desmopressin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Desmopressin Market

A strategic analysis of the Desmopressin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Desmopressin Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Amring Pharmaceuticals Inc., Antares Pharma, Inc. by Halozyme, Inc., Apotex Inc., Avadel Pharmaceuticals PLC, Bachem AG, BluePoint Laboratories, CSC Pharmaceuticals International, Dr. Reddy's Laboratories Ltd., Enomark, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Limited, Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey, KVR Pharmaceuticals, Manus Aktteva Biopharma LLP, Midas Pharma GmbH, NorthStar Rx LLC, Pfizer Inc., Ralington Pharma LLP, Saintroy Lifescience, Sanofi S.A., Sava Healthcare Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Desmopressin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Form, market is studied across Injectable Solution, Nasal Spray, and Tablet.
• Based on Sales Channel, market is studied across Offline and Online.
• Based on End-Users, market is studied across Homecare, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising occurrence of diabetes insipidus in patients worldwide
    • 5.1.1.2. Government initiatives and programs supporting diabetes awareness & treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse effects associated with the desmopressin
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research & development activities for new formulations
    • 5.1.3.2. Increasing in regulatory approvals for desmopressin
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative medicines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Desmopressin Market, by Form

• 6.1. Introduction
• 6.2. Injectable Solution
• 6.3. Nasal Spray
• 6.4. Tablet

7. Desmopressin Market, by Sales Channel

• 7.1. Introduction
• 7.2. Offline
• 7.3. Online

8. Desmopressin Market, by End-Users

• 8.1. Introduction
• 8.2. Homecare
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Desmopressin Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Desmopressin Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Desmopressin Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AA Pharma Inc.
• 2. Amring Pharmaceuticals Inc.
• 3. Antares Pharma, Inc. by Halozyme, Inc.
• 4. Apotex Inc.
• 5. Avadel Pharmaceuticals PLC
• 6. Bachem AG
• 7. BluePoint Laboratories
• 8. CSC Pharmaceuticals International
• 9. Dr. Reddy's Laboratories Ltd.
• 10. Enomark
• 11. Ferring Pharmaceuticals
• 12. Glenmark Pharmaceuticals Limited
• 13. Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
• 14. KVR Pharmaceuticals
• 15. Manus Aktteva Biopharma LLP
• 16. Midas Pharma GmbH
• 17. NorthStar Rx LLC
• 18. Pfizer Inc.
• 19. Ralington Pharma LLP
• 20. Saintroy Lifescience
• 21. Sanofi S.A.
• 22. Sava Healthcare Limited
• 23. Sun Pharmaceutical Industries Limited
• 24. Teva Pharmaceutical Industries Ltd.
• 25. VIVAN Life Sciences Pvt. Limited